Long term survival following cryoablation with adjuvant Toripalimab for anorectal malignant melanoma: a case report

BackgroundAnorectal malignant melanoma is a rare subtype of melanoma with a poor prognosis. Despite this, some patients decline Miles’ operation due to the sigmoid colostomies that follow abdominoperineal resections in cases of anorectal malignant melanoma.Case reportWe report the case of an 80-year...

Full description

Saved in:
Bibliographic Details
Main Authors: Xuejun Jiang, Zujin Ji, Peng Li, Fangjun Yuan, Xinyi Lei, Yong Yang
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2025.1465645/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832589950551326720
author Xuejun Jiang
Zujin Ji
Peng Li
Fangjun Yuan
Xinyi Lei
Yong Yang
author_facet Xuejun Jiang
Zujin Ji
Peng Li
Fangjun Yuan
Xinyi Lei
Yong Yang
author_sort Xuejun Jiang
collection DOAJ
description BackgroundAnorectal malignant melanoma is a rare subtype of melanoma with a poor prognosis. Despite this, some patients decline Miles’ operation due to the sigmoid colostomies that follow abdominoperineal resections in cases of anorectal malignant melanoma.Case reportWe report the case of an 80-year-old woman diagnosed with anorectal malignant melanoma who underwent cryosurgery accompanied by adjuvant PD-1 therapy to maintain anal sphincter function. The results indicated that we successfully achieved the goal of sphincter preservation and therapeutic efficacy. The patient derived significant benefits from the cryoablation treatment.ConclusionsUltrasound-guided trans-anal cryoablation, when combined with adjuvant PD-1 therapy, offers a novel treatment approach for patients with anorectal malignant melanoma. Our results have confirmed the advantages of this treatment regimen, particularly for those desiring to retain anal sphincter function. Further studies are required to substantiate the efficacy of ultrasound-guided trans-anal cryoablation with adjuvant Toripalimab and to elucidate its underlying mechanisms.
format Article
id doaj-art-f0a7676c5dec4cdebba1b39fc0f6c0c9
institution Kabale University
issn 2234-943X
language English
publishDate 2025-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj-art-f0a7676c5dec4cdebba1b39fc0f6c0c92025-01-24T05:21:16ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2025-01-011510.3389/fonc.2025.14656451465645Long term survival following cryoablation with adjuvant Toripalimab for anorectal malignant melanoma: a case reportXuejun Jiang0Zujin Ji1Peng Li2Fangjun Yuan3Xinyi Lei4Yong Yang5Department of Colorectal and Anal Surgery, Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Shiyan, Hubei, ChinaDepartment of Colorectal and Anal Surgery, Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Shiyan, Hubei, ChinaDepartment of Medical Ultrasonics, Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Shiyan, Hubei, ChinaDepartment of General Surgery, Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Shiyan, Hubei, ChinaDepartment of Colorectal and Anal Surgery, Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Shiyan, Hubei, ChinaDepartment of Colorectal and Anal Surgery, Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Shiyan, Hubei, ChinaBackgroundAnorectal malignant melanoma is a rare subtype of melanoma with a poor prognosis. Despite this, some patients decline Miles’ operation due to the sigmoid colostomies that follow abdominoperineal resections in cases of anorectal malignant melanoma.Case reportWe report the case of an 80-year-old woman diagnosed with anorectal malignant melanoma who underwent cryosurgery accompanied by adjuvant PD-1 therapy to maintain anal sphincter function. The results indicated that we successfully achieved the goal of sphincter preservation and therapeutic efficacy. The patient derived significant benefits from the cryoablation treatment.ConclusionsUltrasound-guided trans-anal cryoablation, when combined with adjuvant PD-1 therapy, offers a novel treatment approach for patients with anorectal malignant melanoma. Our results have confirmed the advantages of this treatment regimen, particularly for those desiring to retain anal sphincter function. Further studies are required to substantiate the efficacy of ultrasound-guided trans-anal cryoablation with adjuvant Toripalimab and to elucidate its underlying mechanisms.https://www.frontiersin.org/articles/10.3389/fonc.2025.1465645/fullanorectal malignant melanomacryosurgerysphincter preservationcase reportToripalimabPD-1
spellingShingle Xuejun Jiang
Zujin Ji
Peng Li
Fangjun Yuan
Xinyi Lei
Yong Yang
Long term survival following cryoablation with adjuvant Toripalimab for anorectal malignant melanoma: a case report
Frontiers in Oncology
anorectal malignant melanoma
cryosurgery
sphincter preservation
case report
Toripalimab
PD-1
title Long term survival following cryoablation with adjuvant Toripalimab for anorectal malignant melanoma: a case report
title_full Long term survival following cryoablation with adjuvant Toripalimab for anorectal malignant melanoma: a case report
title_fullStr Long term survival following cryoablation with adjuvant Toripalimab for anorectal malignant melanoma: a case report
title_full_unstemmed Long term survival following cryoablation with adjuvant Toripalimab for anorectal malignant melanoma: a case report
title_short Long term survival following cryoablation with adjuvant Toripalimab for anorectal malignant melanoma: a case report
title_sort long term survival following cryoablation with adjuvant toripalimab for anorectal malignant melanoma a case report
topic anorectal malignant melanoma
cryosurgery
sphincter preservation
case report
Toripalimab
PD-1
url https://www.frontiersin.org/articles/10.3389/fonc.2025.1465645/full
work_keys_str_mv AT xuejunjiang longtermsurvivalfollowingcryoablationwithadjuvanttoripalimabforanorectalmalignantmelanomaacasereport
AT zujinji longtermsurvivalfollowingcryoablationwithadjuvanttoripalimabforanorectalmalignantmelanomaacasereport
AT pengli longtermsurvivalfollowingcryoablationwithadjuvanttoripalimabforanorectalmalignantmelanomaacasereport
AT fangjunyuan longtermsurvivalfollowingcryoablationwithadjuvanttoripalimabforanorectalmalignantmelanomaacasereport
AT xinyilei longtermsurvivalfollowingcryoablationwithadjuvanttoripalimabforanorectalmalignantmelanomaacasereport
AT yongyang longtermsurvivalfollowingcryoablationwithadjuvanttoripalimabforanorectalmalignantmelanomaacasereport